Table III.
Subgroup | #of subgroups |
Variance in treatment effects explained by subgroups (%) |
Variance in treatment effects explained by subgroups (%) |
---|---|---|---|
Gender | 2 | 1.2 | 1.0 |
Race | 4 | 4.5 | 1.0 |
Age | 47 | 4.2 | 2.1 |
Total number of comorbidities | 15 | 46.7 | 18.4 |
Unique combinations of comorbidities |
5,905 | 87.8 | 67.1 |